Related Experiment Video
Updated: Dec 9, 2025
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
13.1K
Heme oxygenase-1 in osteosarcoma
Simmi Kharb1, M Halder1, Z S Kundu1
1Department of Biochemistry and Orthopedics, Pt. B. D. S. PGIMS, Rohtak, Haryana, India.
Journal of Cancer Research and Therapeutics
|September 15, 2020
Summary
Serum heme oxygenase-1 (HO-1) levels are elevated in osteosarcoma patients compared to controls. This suggests HO-1 may play a role in cancer progression and could be a target for future therapies.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Heme oxygenase-1 (HO-1) is known for its protective role against oxidative stress.
- HO-1 also influences cell proliferation, inflammation, and angiogenesis.
- Limited data exists on HO-1 blood levels in osteosarcoma.
Purpose of the Study:
- To investigate serum heme oxygenase-1 (HO-1) levels in osteosarcoma patients.
- To compare HO-1 levels between osteosarcoma patients and a control group.
Main Methods:
- Serum samples were collected from 25 osteosarcoma patients and 25 controls with musculoskeletal pain.
- Serum heme oxygenase-1 (HO-1) was quantified using enzyme-linked immunosorbent assay (ELISA).
- Routine biochemical analyses were performed using standard enzymatic methods.
Main Results:
- Serum HO-1 levels were significantly higher in osteosarcoma patients compared to the control group (P < 0.05).
- Previous research indicated HO-1 induction can restore osteoblast proliferation inhibited by prostate cancer cells.
Conclusions:
- Elevated serum HO-1 levels in osteosarcoma suggest its potential involvement in cancer development.
- Modulating HO-1 activity or gene expression could offer novel therapeutic strategies for various cancers.
- Targeting HO-1 may enhance sensitivity to existing anticancer treatments.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
01:27Oxygen Transport in the Blood
5.2K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
5.2K
01:24Regulation of Angiogenesis and Blood Supply
3.1K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K